Current Opinion in Pharmacology, ISSN 1471-4892, 2016, Volume 32, pp. 85 - 90
Highlights • GPCR-linked signaling is pleiotropic and involves multiple intracellular pathways. • Biased ligands favor particular signaling pathways at the...
Internal Medicine | Medical Education | DESIGN | BIASED AGONISM | ALLOSTERIC MODULATORS | EFFICACY | PHOSPHORYLATION | DRUG DISCOVERY | HEART-FAILURE | PROTEIN-COUPLED RECEPTORS | PHARMACOLOGY & PHARMACY | LIGAND | MU-OPIOID RECEPTOR | Receptors, Angiotensin - metabolism | Receptors, G-Protein-Coupled - metabolism | Receptors, Opioid, mu - metabolism | Humans | Receptors, G-Protein-Coupled - agonists | Receptors, Opioid, mu - agonists | Molecular Targeted Therapy | Animals | Receptors, Angiotensin - agonists | Signal Transduction - drug effects | Drug Design | Protein Binding | Ligands | G proteins | Membrane proteins
Internal Medicine | Medical Education | DESIGN | BIASED AGONISM | ALLOSTERIC MODULATORS | EFFICACY | PHOSPHORYLATION | DRUG DISCOVERY | HEART-FAILURE | PROTEIN-COUPLED RECEPTORS | PHARMACOLOGY & PHARMACY | LIGAND | MU-OPIOID RECEPTOR | Receptors, Angiotensin - metabolism | Receptors, G-Protein-Coupled - metabolism | Receptors, Opioid, mu - metabolism | Humans | Receptors, G-Protein-Coupled - agonists | Receptors, Opioid, mu - agonists | Molecular Targeted Therapy | Animals | Receptors, Angiotensin - agonists | Signal Transduction - drug effects | Drug Design | Protein Binding | Ligands | G proteins | Membrane proteins
Journal Article
Neuropharmacology, ISSN 0028-3908, 07/2018, Volume 136, Issue Pt C, pp. 427 - 437
Muscarinic acetylcholine receptors are G protein-coupled receptors (GPCRs) which are broadly expressed in the central nervous system (CNS) and other tissues in...
Bitopic ligands | Biased signaling | Subtype-selectivity | Dualsteric ligands | Allosteric modulation | Muscarinic acetylcholine receptors | MLPCN PROBE MOLECULE | M-1 PAM ML137 | CONFORMATIONAL DYNAMICS | NEUROSCIENCES | ACETYLCHOLINE-RECEPTOR | SUBTYPE SELECTIVITY | PROTEIN-COUPLED RECEPTOR | DRUG DEVELOPMENT | FUNCTIONAL SELECTIVITY | PHARMACOLOGY & PHARMACY | RATIONAL DESIGN | Drug discovery | G proteins
Bitopic ligands | Biased signaling | Subtype-selectivity | Dualsteric ligands | Allosteric modulation | Muscarinic acetylcholine receptors | MLPCN PROBE MOLECULE | M-1 PAM ML137 | CONFORMATIONAL DYNAMICS | NEUROSCIENCES | ACETYLCHOLINE-RECEPTOR | SUBTYPE SELECTIVITY | PROTEIN-COUPLED RECEPTOR | DRUG DEVELOPMENT | FUNCTIONAL SELECTIVITY | PHARMACOLOGY & PHARMACY | RATIONAL DESIGN | Drug discovery | G proteins
Journal Article
Nature Communications, ISSN 2041-1723, 2015, Volume 6, Issue 1, pp. 10156 - 10156
Despite the discovery of heterotrimeric alpha beta gamma G proteins similar to 25 years ago, their selective perturbation by cell-permeable inhibitors remains...
ADENYLATE-CYCLASE SYSTEM | 7-TRANSMEMBRANE RECEPTORS | ACTIVATION | HETEROTRIMERIC G-PROTEINS | G-ALPHA | SMALL-MOLECULE | MULTIDISCIPLINARY SCIENCES | PHOSPHOLIPASE-C | IN-VIVO | PROTEIN-COUPLED RECEPTORS | CYCLIC DEPSIPEPTIDE | Melanoma - metabolism | GTP-Binding Protein alpha Subunits, Gq-G11 - genetics | Signal Transduction | Humans | Models, Molecular | Depsipeptides - pharmacology | Vasoconstriction - drug effects | Animals | Ardisia - chemistry | Protein Isoforms | Tail - blood supply | Cell Line, Tumor | Protein Conformation | Mice | Molecular Structure | Gene Expression Regulation, Neoplastic - drug effects | GTP-Binding Protein alpha Subunits, Gq-G11 - metabolism | Depsipeptides - chemistry | Proteins | Signaling | Perturbation | Biological activity | Index Medicus
ADENYLATE-CYCLASE SYSTEM | 7-TRANSMEMBRANE RECEPTORS | ACTIVATION | HETEROTRIMERIC G-PROTEINS | G-ALPHA | SMALL-MOLECULE | MULTIDISCIPLINARY SCIENCES | PHOSPHOLIPASE-C | IN-VIVO | PROTEIN-COUPLED RECEPTORS | CYCLIC DEPSIPEPTIDE | Melanoma - metabolism | GTP-Binding Protein alpha Subunits, Gq-G11 - genetics | Signal Transduction | Humans | Models, Molecular | Depsipeptides - pharmacology | Vasoconstriction - drug effects | Animals | Ardisia - chemistry | Protein Isoforms | Tail - blood supply | Cell Line, Tumor | Protein Conformation | Mice | Molecular Structure | Gene Expression Regulation, Neoplastic - drug effects | GTP-Binding Protein alpha Subunits, Gq-G11 - metabolism | Depsipeptides - chemistry | Proteins | Signaling | Perturbation | Biological activity | Index Medicus
Journal Article
Nature Communications, ISSN 2041-1723, 2012, Volume 3, Issue 1, p. 1044
Seven transmembrane helical receptors (7TMRs) modulate cell function via different types of G proteins, often in a ligand-specific manner. Class A 7TMRs...
SITE | 7-TRANSMEMBRANE RECEPTORS | ACTIVATION | LIGANDS | CRYSTAL-STRUCTURE | AMINO-ACIDS | MULTIDISCIPLINARY SCIENCES | DRUG DISCOVERY | FUNCTIONAL SELECTIVITY | MUSCARINIC ACETYLCHOLINE-RECEPTORS | LIVING CELLS | Protein Structure, Tertiary | Receptor, Muscarinic M2 - genetics | Protein Structure, Secondary | Receptor, Muscarinic M2 - metabolism | Receptors, G-Protein-Coupled - metabolism | Humans | Allosteric Site | Receptors, G-Protein-Coupled - genetics | Receptor, Muscarinic M2 - chemistry | Receptors, G-Protein-Coupled - chemistry | GTP-Binding Proteins - metabolism
SITE | 7-TRANSMEMBRANE RECEPTORS | ACTIVATION | LIGANDS | CRYSTAL-STRUCTURE | AMINO-ACIDS | MULTIDISCIPLINARY SCIENCES | DRUG DISCOVERY | FUNCTIONAL SELECTIVITY | MUSCARINIC ACETYLCHOLINE-RECEPTORS | LIVING CELLS | Protein Structure, Tertiary | Receptor, Muscarinic M2 - genetics | Protein Structure, Secondary | Receptor, Muscarinic M2 - metabolism | Receptors, G-Protein-Coupled - metabolism | Humans | Allosteric Site | Receptors, G-Protein-Coupled - genetics | Receptor, Muscarinic M2 - chemistry | Receptors, G-Protein-Coupled - chemistry | GTP-Binding Proteins - metabolism
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2015, Volume 10, Issue 9, p. e0138986
The endocannabinoid system (ECS) is a retrograde messenger system, consisting of lipid signaling molecules that bind to at least two G-protein-coupled...
SYSTEM | ACTIVATION | B-CELL | MARGINAL ZONE | RETENTION | MULTIDISCIPLINARY SCIENCES | CANNABINOID CB2 RECEPTORS | LYMPHOCYTES | Green Fluorescent Proteins - metabolism | Promoter Regions, Genetic | Mice, Transgenic | Green Fluorescent Proteins - blood | Green Fluorescent Proteins - genetics | Receptor, Cannabinoid, CB2 - blood | Receptor, Cannabinoid, CB2 - genetics | Brain - metabolism | Chromosomes, Artificial, Bacterial - genetics | Receptor, Cannabinoid, CB2 - metabolism | Animals | Spleen - metabolism | Mice | Thymus Gland - metabolism | B-Lymphocytes - metabolism | Physiological aspects | Genetic engineering | Research | B cells | Dendritic cells | Brain | Animal models | G protein-coupled receptors | Transcription | Trafficking | Antibodies | Fluorescence | Lymphocytes T | Macrophages | Bacterial artificial chromosomes | Cell adhesion & migration | Thymus | Receptors | Lymphocytes | Transgenic animals | Rodents | Labeling | Immune system | Spleen | Immunoglobulins | Dopamine | Cloning | Transgenic mice | Microglia | Lymphocytes B | Psychiatry
SYSTEM | ACTIVATION | B-CELL | MARGINAL ZONE | RETENTION | MULTIDISCIPLINARY SCIENCES | CANNABINOID CB2 RECEPTORS | LYMPHOCYTES | Green Fluorescent Proteins - metabolism | Promoter Regions, Genetic | Mice, Transgenic | Green Fluorescent Proteins - blood | Green Fluorescent Proteins - genetics | Receptor, Cannabinoid, CB2 - blood | Receptor, Cannabinoid, CB2 - genetics | Brain - metabolism | Chromosomes, Artificial, Bacterial - genetics | Receptor, Cannabinoid, CB2 - metabolism | Animals | Spleen - metabolism | Mice | Thymus Gland - metabolism | B-Lymphocytes - metabolism | Physiological aspects | Genetic engineering | Research | B cells | Dendritic cells | Brain | Animal models | G protein-coupled receptors | Transcription | Trafficking | Antibodies | Fluorescence | Lymphocytes T | Macrophages | Bacterial artificial chromosomes | Cell adhesion & migration | Thymus | Receptors | Lymphocytes | Transgenic animals | Rodents | Labeling | Immune system | Spleen | Immunoglobulins | Dopamine | Cloning | Transgenic mice | Microglia | Lymphocytes B | Psychiatry
Journal Article
Angewandte Chemie International Edition, ISSN 1433-7851, 01/2013, Volume 52, Issue 2, pp. 508 - 516
Cell‐membrane‐spanning G protein coupled receptors (GPCRs) belong to the most important therapeutic target structures. Endogenous transmitters bind from the...
antagonists | agonists | receptors | allosterism | dualsterism | DESIGN | COMPLEX | CRYSTAL-STRUCTURE | MODULATORS | DRUG DISCOVERY | THERAPEUTIC OPPORTUNITIES | CHEMISTRY, MULTIDISCIPLINARY | MUSCARINIC ACETYLCHOLINE-RECEPTORS | OPIOID RECEPTOR | BIVALENT LIGANDS | BINDING-SITES | Receptors, G-Protein-Coupled - metabolism | Signal Transduction | Allosteric Regulation | Humans | Allosteric Site | Drug Design | Models, Molecular | Protein Binding | Ligands | Receptors, G-Protein-Coupled - chemistry
antagonists | agonists | receptors | allosterism | dualsterism | DESIGN | COMPLEX | CRYSTAL-STRUCTURE | MODULATORS | DRUG DISCOVERY | THERAPEUTIC OPPORTUNITIES | CHEMISTRY, MULTIDISCIPLINARY | MUSCARINIC ACETYLCHOLINE-RECEPTORS | OPIOID RECEPTOR | BIVALENT LIGANDS | BINDING-SITES | Receptors, G-Protein-Coupled - metabolism | Signal Transduction | Allosteric Regulation | Humans | Allosteric Site | Drug Design | Models, Molecular | Protein Binding | Ligands | Receptors, G-Protein-Coupled - chemistry
Journal Article
Angewandte Chemie, ISSN 1433-7851, 01/2013, Volume 52, Issue 2, pp. 508 - 516
Cell-membrane-spanning Gprotein coupled receptors (GPCRs) belong to the most important therapeutic target structures. Endogenous transmitters bind from the...
Proteins | Binding sites | Drugs | Binding | Receptors | Side effects | Activation | Selectivity | Modulators
Proteins | Binding sites | Drugs | Binding | Receptors | Side effects | Activation | Selectivity | Modulators
Journal Article
Science Signaling, ISSN 1945-0877, 03/2019, Volume 12, Issue 573, p. eaau5948
Somatic gain-of-function mutations of GNAQ and GNA11, which encode α subunits of heterotrimeric Gαq/11 proteins, occur in about 85% of cases of uveal melanoma...
Cell proliferation | Cell culture | GTP | Xenotransplantation | Guanosine | Melanoma | Radiation | Extracellular signal-regulated kinase | Patients | Mutants | Metastases | Phospholipase C | Proteins | Phospholipase | Signal transduction | Signaling | Surgery | Cell lines | Xenografts | Mutation | Inhibition | Cancer | Guanosinetriphosphatase | Tumors
Cell proliferation | Cell culture | GTP | Xenotransplantation | Guanosine | Melanoma | Radiation | Extracellular signal-regulated kinase | Patients | Mutants | Metastases | Phospholipase C | Proteins | Phospholipase | Signal transduction | Signaling | Surgery | Cell lines | Xenografts | Mutation | Inhibition | Cancer | Guanosinetriphosphatase | Tumors
Journal Article
PloS one, ISSN 1932-6203, 2015, Volume 10, Issue 12, p. e0145472
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 01/2015, Volume 58, Issue 2, pp. 560 - 576
Aiming to design partial agonists for a G-protein-coupled receptor based on dynamic ligand binding, we synthesized three different series of bipharmacophoric...
Receptor, Muscarinic M1 - agonists | Animals | Cricetulus | Muscarinic Agonists - pharmacology | Drug Design | Structure-Activity Relationship | CHO Cells | Muscarinic Agonists - chemical synthesis
Receptor, Muscarinic M1 - agonists | Animals | Cricetulus | Muscarinic Agonists - pharmacology | Drug Design | Structure-Activity Relationship | CHO Cells | Muscarinic Agonists - chemical synthesis
Journal Article
Science Signaling, ISSN 1945-0877, 10/2013, Volume 6, Issue 298, pp. ra93 - ra93
Replacement of the lost myelin sheath is a therapeutic goal for treating demyelinating diseases of the central nervous system (CNS), such as multiple sclerosis...
INVERSE AGONISTS | HEK-293 CELLS | 7-TRANSMEMBRANE RECEPTORS | MULTIPLE-SCLEROSIS | ARRESTIN-BIASED AGONISM | PHARMACOLOGICAL CHARACTERIZATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | P2Y RECEPTOR | DRUG TARGETS | OLIGODENDROCYTES | LIVING CELLS | CELL BIOLOGY | Immunohistochemistry | Propionates - pharmacology | Oligodendroglia - metabolism | Small Molecule Libraries - pharmacology | Cricetulus | Rats, Wistar | Receptors, G-Protein-Coupled - metabolism | Humans | Stem Cells - cytology | Receptors, G-Protein-Coupled - agonists | Stem Cells - metabolism | Arrestins - metabolism | Oligodendroglia - drug effects | HEK293 Cells | Indoles - pharmacology | Molecular Structure | Oligodendroglia - cytology | Chromones - pharmacology | CHO Cells | Cell Line | Propionates - chemistry | Cricetinae | Nerve Tissue Proteins - agonists | Cells, Cultured | Rats | Nerve Tissue Proteins - genetics | Mice, Knockout | Nerve Tissue Proteins - metabolism | Small Molecule Libraries - chemistry | Animals | Signal Transduction - drug effects | beta-Arrestins | Cell Line, Tumor | Stem Cells - drug effects | Mice | Receptors, G-Protein-Coupled - genetics | COS Cells | Indoles - chemistry
INVERSE AGONISTS | HEK-293 CELLS | 7-TRANSMEMBRANE RECEPTORS | MULTIPLE-SCLEROSIS | ARRESTIN-BIASED AGONISM | PHARMACOLOGICAL CHARACTERIZATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | P2Y RECEPTOR | DRUG TARGETS | OLIGODENDROCYTES | LIVING CELLS | CELL BIOLOGY | Immunohistochemistry | Propionates - pharmacology | Oligodendroglia - metabolism | Small Molecule Libraries - pharmacology | Cricetulus | Rats, Wistar | Receptors, G-Protein-Coupled - metabolism | Humans | Stem Cells - cytology | Receptors, G-Protein-Coupled - agonists | Stem Cells - metabolism | Arrestins - metabolism | Oligodendroglia - drug effects | HEK293 Cells | Indoles - pharmacology | Molecular Structure | Oligodendroglia - cytology | Chromones - pharmacology | CHO Cells | Cell Line | Propionates - chemistry | Cricetinae | Nerve Tissue Proteins - agonists | Cells, Cultured | Rats | Nerve Tissue Proteins - genetics | Mice, Knockout | Nerve Tissue Proteins - metabolism | Small Molecule Libraries - chemistry | Animals | Signal Transduction - drug effects | beta-Arrestins | Cell Line, Tumor | Stem Cells - drug effects | Mice | Receptors, G-Protein-Coupled - genetics | COS Cells | Indoles - chemistry
Journal Article
12.
Full Text
The orphan receptor GPR17 is unresponsive to uracil nucleotides and cysteinyl leukotrienes
Molecular Pharmacology, ISSN 0026-895X, 05/2017, Volume 91, Issue 5, pp. 518 - 532
Pairing orphan G protein-coupled receptors (GPCRs) with their cognate endogenous ligands is expected to have a major impact on our understanding of GPCR...
CELLS | 7-TRANSMEMBRANE RECEPTORS | ACTIVATION | LIGANDS | PROTEIN-COUPLED RECEPTOR | ARRESTIN-BIASED AGONISM | FREE FATTY-ACIDS | PHARMACOLOGY & PHARMACY | IDENTIFICATION | DRUG TARGETS | BRAIN | Small Molecule Libraries - pharmacology | Cricetinae | Cricetulus | Receptors, G-Protein-Coupled - metabolism | Humans | Leukotrienes - pharmacology | Rats | Adenosine - pharmacology | Uracil Nucleotides - pharmacology | Nerve Tissue Proteins - metabolism | Animals | Signal Transduction - drug effects | Adenosine - analogs & derivatives | Adenosine Monophosphate - analogs & derivatives | Cysteine - pharmacology | HEK293 Cells | Ligands | Adenosine Monophosphate - pharmacology | Cell Membrane - metabolism | Mice | Cell Membrane - drug effects | CHO Cells | Index Medicus
CELLS | 7-TRANSMEMBRANE RECEPTORS | ACTIVATION | LIGANDS | PROTEIN-COUPLED RECEPTOR | ARRESTIN-BIASED AGONISM | FREE FATTY-ACIDS | PHARMACOLOGY & PHARMACY | IDENTIFICATION | DRUG TARGETS | BRAIN | Small Molecule Libraries - pharmacology | Cricetinae | Cricetulus | Receptors, G-Protein-Coupled - metabolism | Humans | Leukotrienes - pharmacology | Rats | Adenosine - pharmacology | Uracil Nucleotides - pharmacology | Nerve Tissue Proteins - metabolism | Animals | Signal Transduction - drug effects | Adenosine - analogs & derivatives | Adenosine Monophosphate - analogs & derivatives | Cysteine - pharmacology | HEK293 Cells | Ligands | Adenosine Monophosphate - pharmacology | Cell Membrane - metabolism | Mice | Cell Membrane - drug effects | CHO Cells | Index Medicus
Journal Article
Molecular Pharmacology, ISSN 0026-895X, 04/2017, Volume 91, Issue 4, pp. 348 - 356
Protean agonists are of great pharmacological interest as their behavior may change in magnitude and direction depending on the constitutive activity of a...
IN-VITRO | 7-TRANSMEMBRANE RECEPTORS | STRUCTURAL BASIS | PHARMACOLOGICAL CHARACTERIZATION | CONSTITUTIVE ACTIVATION | PHARMACOLOGY & PHARMACY | FUNCTIONAL-CHARACTERIZATION | ADRENERGIC-RECEPTOR | BINDING-SITES | ALLOSTERIC SITE | MUSCARINIC ACETYLCHOLINE-RECEPTORS | Cricetinae | Cricetulus | Receptor, Muscarinic M2 - metabolism | Receptors, G-Protein-Coupled - metabolism | Allosteric Regulation | Humans | Receptors, G-Protein-Coupled - agonists | Animals | Protein Engineering | Protein Binding | Ligands | CHO Cells | Tromethamine | Index Medicus
IN-VITRO | 7-TRANSMEMBRANE RECEPTORS | STRUCTURAL BASIS | PHARMACOLOGICAL CHARACTERIZATION | CONSTITUTIVE ACTIVATION | PHARMACOLOGY & PHARMACY | FUNCTIONAL-CHARACTERIZATION | ADRENERGIC-RECEPTOR | BINDING-SITES | ALLOSTERIC SITE | MUSCARINIC ACETYLCHOLINE-RECEPTORS | Cricetinae | Cricetulus | Receptor, Muscarinic M2 - metabolism | Receptors, G-Protein-Coupled - metabolism | Allosteric Regulation | Humans | Receptors, G-Protein-Coupled - agonists | Animals | Protein Engineering | Protein Binding | Ligands | CHO Cells | Tromethamine | Index Medicus
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 08/2014, Volume 57, Issue 15, pp. 6739 - 6750
Bivalent ligands of G protein-coupled receptors have been shown to simultaneously either bind to two adjacent receptors or to bridge different parts of one...
ACETYLCHOLINE-RECEPTORS | CHEMISTRY, MEDICINAL | LIGAND-BINDING | CRYSTAL-STRUCTURE | AMINO-ACIDS | THERAPEUTIC OPPORTUNITIES | PROTEIN-COUPLED RECEPTORS | FUNCTIONAL-CHARACTERIZATION | OXOTREMORINE-M | DERIVATIVES | GENETIC ALGORITHM | Receptor, Muscarinic M2 - agonists | Receptor, Muscarinic M2 - genetics | Cricetulus | Muscarinic Agonists - pharmacology | Stereoisomerism | Allosteric Regulation | Humans | Molecular Conformation | Atropine Derivatives - pharmacology | Phthalimides - chemistry | Structure-Activity Relationship | Muscarinic Agonists - chemical synthesis | Phthalimides - pharmacology | Naphthalimides - chemical synthesis | Phthalimides - chemical synthesis | Muscarinic Antagonists - pharmacology | Receptor, Muscarinic M2 - antagonists & inhibitors | Naphthalimides - chemistry | Radioligand Assay | Binding Sites | Scopolamine Derivatives - chemical synthesis | CHO Cells | Atropine Derivatives - chemistry | Scopolamine Derivatives - pharmacology | Muscarinic Antagonists - chemical synthesis | Scopolamine Derivatives - chemistry | Muscarinic Antagonists - chemistry | Molecular Dynamics Simulation | Animals | Naphthalimides - pharmacology | Drug Inverse Agonism | Atropine Derivatives - chemical synthesis | Molecular Docking Simulation | Muscarinic Agonists - chemistry | Mutation | Index Medicus
ACETYLCHOLINE-RECEPTORS | CHEMISTRY, MEDICINAL | LIGAND-BINDING | CRYSTAL-STRUCTURE | AMINO-ACIDS | THERAPEUTIC OPPORTUNITIES | PROTEIN-COUPLED RECEPTORS | FUNCTIONAL-CHARACTERIZATION | OXOTREMORINE-M | DERIVATIVES | GENETIC ALGORITHM | Receptor, Muscarinic M2 - agonists | Receptor, Muscarinic M2 - genetics | Cricetulus | Muscarinic Agonists - pharmacology | Stereoisomerism | Allosteric Regulation | Humans | Molecular Conformation | Atropine Derivatives - pharmacology | Phthalimides - chemistry | Structure-Activity Relationship | Muscarinic Agonists - chemical synthesis | Phthalimides - pharmacology | Naphthalimides - chemical synthesis | Phthalimides - chemical synthesis | Muscarinic Antagonists - pharmacology | Receptor, Muscarinic M2 - antagonists & inhibitors | Naphthalimides - chemistry | Radioligand Assay | Binding Sites | Scopolamine Derivatives - chemical synthesis | CHO Cells | Atropine Derivatives - chemistry | Scopolamine Derivatives - pharmacology | Muscarinic Antagonists - chemical synthesis | Scopolamine Derivatives - chemistry | Muscarinic Antagonists - chemistry | Molecular Dynamics Simulation | Animals | Naphthalimides - pharmacology | Drug Inverse Agonism | Atropine Derivatives - chemical synthesis | Molecular Docking Simulation | Muscarinic Agonists - chemistry | Mutation | Index Medicus
Journal Article